AB
HARP

Amalgamated Bank’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Amalgamated Bank’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-305
Closed -$15K – 3279
2022
Q1 		$15K Buy
+305
New +$15.8K ﹤0.01% 2886

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Amalgamated Bank's HARP Position: Q2 2022 in Review

Amalgamated Bank sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 305 shares — an estimated $15K sold.

Amalgamated Bank first reported a position in HARP in Q1 2022 and held it in 1 quarter. The position peaked at $15K in Q1 2022. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

  • Amalgamated Bank reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 305 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $15K.
  • Amalgamated Bank first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Harpoon Therapeutics, Inc. Common Stock position peaked at $15K in Q1 2022.
  • 63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.